BIAF

bioAffinity Technologies, Inc. Common Stock

7.83

USD

-0.11

-1.39%

Sep 24, 15:59 UTC -4

Closed

Pre-Market

7.88

+0.04

+0.57%

bioAffinity Technologies, Inc. Common Stock Profile

About

bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.

Info & Links

CEO

Maria Zannes

Headquarters

3300 NACOGDOCHES ROAD, SUITE 216
SAN ANTONIO, TX 78217, UNITED STATES

Auditor

WithumSmith+Brown, PC

Share holders

Employees

bioAffinity Technologies, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

4.73M

Enterprise Value

2.94M

Enterprise Value/EBITDA(ttm)

-0.25

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.87

Price to Book(mrq)

1.03

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

34.40%

Operating Margin(ttm)

-220.54%

Profit Margin(ttm)

-259.43%

Return on Equity(ttm)

-220.52%

Return on Invested Capital(ttm)

-260.81%

Return on Assets(ttm)

-136.76%

Income Statement

Revenue(ttm)

5.90M

Revenue Per Share(ttm)

10.92

Gross Profit(ttm)

2.04M

EBITDA(ttm)³

-11.97M

Net Income Available to Common(ttm)

-15.19M

Diluted EPS(ttm)

-109.45

Share Statistics

Beta (5Y Monthly)

-1.11

52-Week Change

-87.83%

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

540.38K

Dividend Yield

0.00%

Float⁴

585.00K

% Held by Insiders

2.68%

% Held by Institutions

1.64%

Balance Sheet

Total Cash(mrq)

2.43M

Total Cash Per Share(mrq)

4.50

Total Debt(mrq)

634.10K

Total Debt/Equity(mrq)

16.82%

Current Ratio(mrq)

1.44%

Quick Ratio(mrq)

1.41%

Book Value Per Share(mrq)

8.33

Cash Flow

Operating Cash Flow Per Share(ytd)

-18.44

Free Cash Flow(ytd)

-6.52M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.